ChromaDexs Patented Nicotinamide Riboside Ingredient, Niagen, Featured as the Hero Ingredient in Longevity.Technologys Inaugural Longevity Supplement
CDXC Stock | USD 7.44 0.19 2.49% |
About 61% of Chromadex Corp's investor base is looking to short. The analysis of overall sentiment of trading Chromadex Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Chromadex Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Chromadex Corp stock news signals to limit their universe of possible portfolio assets.
Chromadex |
ChromaDex Corp. , the global authority on nicotinamide adenine dinucleotide with a focus on the science of healthy aging, announc
Read at businesswire.com
Chromadex Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Chromadex Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Chromadex Corp Fundamental Analysis
We analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Chromadex Corp is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Chromadex Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chromadex Corp stock to make a market-neutral strategy. Peer analysis of Chromadex Corp could also be used in its relative valuation, which is a method of valuing Chromadex Corp by comparing valuation metrics with similar companies.
Peers
Chromadex Corp Related Equities
XCUR | Exicure | 69.24 | ||||
ANTX | AN2 Therapeutics | 8.94 | ||||
HCWB | HCW Biologics | 8.45 | ||||
JANX | Janux Therapeutics | 8.19 | ||||
MNOV | MediciNova | 6.50 | ||||
MLYS | Mineralys Therapeutics, | 5.22 | ||||
AVTE | Aerovate Therapeutics | 1.92 | ||||
ACRV | Acrivon Therapeutics, | 1.71 | ||||
RZLT | Rezolute | 1.03 | ||||
IKNA | Ikena Oncology | 1.16 | ||||
KZR | Kezar Life | 1.57 | ||||
NKTX | Nkarta | 2.40 | ||||
IPSC | Century Therapeutics | 2.42 | ||||
ELYM | Eliem Therapeutics | 2.60 | ||||
ANEB | Anebulo Pharmaceuticals | 2.67 | ||||
ADAG | Adagene | 3.10 |
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |